What are the payment terms?

Accepted payment terms include LC, T/T, and D/P.

What is the lead time for orders?

The average lead time is 1-3 months for both peak and off-season periods.

Vancomycin for Injection with GMP From Reyoung Pharma

Name: Vancomycin for Injection with GMP From Reyoung Pharma
Brand: REYOUNG PHARMACEUTICAL CO., LTD.
SKU: 758715842

Shandong, ChinaREYOUNG PHARMACEUTICAL CO., LTD.

US$0.40-0.45

100,000 pcs

Product profile

Customization

Available

Application

Anti-Infective

Usage Mode

Intravenous Injection

Model NO.

500mg/1g

Suitable for

Elderly, Children, Adult

State

Solid

Shape

Powder

Type

Biological Products

Pharmaceutical Technology

Chemical Synthesis

Packaging

1/10/50vial/Box

Standard

USP

Transport Package

Box

Specification

500mg/1g

Trademark

Reyoung

Origin

No.1, Ruiyang Road, Yiyuan County, Shandong Provin

Key features

GMP Certified Manufacturer: Produced by Reyoung Pharma, a GMP-certified manufacturer established in 1998.

Broad Anti-Infective Use: Treats serious infections like endocarditis, peritonitis, and blood or bone infections.

Customizable Packaging: Packaging options available in 1, 10, or 50 vials per box to meet specific needs.

USP Standard Compliance: Meets USP standards for quality and purity in pharmaceutical production.

OEM/ODM Services: Offers both OEM and ODM services with 370 R&D engineers supporting innovation.

Large Scale Production: Manufactured in a 1,080,000 sqm plant with 4,950 employees and advanced machinery.

Global Market Reach: Exports to South America, Southeast Asia, Middle East, and Africa with $112M annual revenue.

Flexible Payment Terms: Accepts LC, T/T, and D/P payment terms for international trade convenience.

Company profile

REYOUNG PHARMACEUTICAL CO., LTD.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 1997-01-01 CertifiedNearest Port: Qingdao PortAverage Response Time: >24h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryREYOUNG PHARMACEUTICAL CO., LTD. is a China-based limited company established in 1998, with 4,950 employees and operations in Shandong. The supplier reports ISO 9001, ISO 14001, and OHSAS 18001 certifications, more than 10 production lines, 50 quality-control staff, and 370 years of combined R&D-engineer experience. Its stated manufacturing portfolio includes sterile raw materials, powders and liquids for injection, tablets, and capsules, with reported annual production above the stated threshold. The company identifies three factories, an extensive manufacturing area, international business since 1997, and export markets across South America, Africa, Southeast Asia, and the Middle East. Trade records show transactions involving India, Bolivia, and Vietnam, including cefotaxime-related products. Evidence is insufficient to assess after-sales service, financial credibility, innovation output, or customization capability. Customer-case evidence is limited to named buyers and trade records.

Supplier typeThe supplier is identified as a combined business entity and a limited company headquartered in Shandong, China. Its business scope is health and medicine, with products including sterile raw materials, injectable products, tablets, and capsules, supporting classification as a pharmaceutical manufacturer and distributor.

CertificationsThe supplier explicitly reports ISO 9001:2015, ISO 14001:2015, and OHSAS 18001:2007 certificates, and separately describes itself as GMP and ISO authenticated. These stated certifications provide direct evidence of formal quality, environmental, and occupational-health management systems.

Production capacityProduction capacity is supported by more than 10 production lines, three factories, a reported manufacturing area of 1,000,000 square meters, and stated annual output across small-volume injections, powder injections, tablets, and capsules. The supplier also reports annual production above the stated threshold, indicating substantial multi-form pharmaceutical manufacturing capability.

Client casesTrade records identify transactions involving STERILE INDIA PRIVATE LIMITED, HEREDIA ARACENA RENY EVELIN, and a Vietnam-related registration, with products including cefotaxime-related material and oral rehydration products. These records demonstrate some international commercial activity, but the evidence is limited and does not establish long-term customer performance or a broad verified customer portfolio.